<\/p>\n
NEW FILINGS<\/strong><\/p>\n Company: TELA Bio, Inc. Company: Galera Therapeutics, Inc. Company: 89bio, Inc. Company: Centogene NV TERMS ADDED<\/strong><\/p>\n Company: Progyny, Inc. Company: Phathom Pharmaceuticals, Inc. Company: OneWater Marine Inc. Company: Youdao, Inc Company: Aesthetic Medical International Holdings Group Limited Company: Cabaletta Bio, Inc.
\nSymbol: TELA
\nDescription: They are a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Piper Jaffray
\nCo-Manager: Canaccord Genuity, JMP Securities
\nFiled: 10-15-19
\nListed Cash Raise: $69m<\/p>\n
\nSymbol: GRTX
\nDescription: They are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, Citigroup, Credit Suisse
\nCo-Manager: BTIG
\nFiled: 10-11-19
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: ETNB
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Merrill Lynch, SVB Leerink, RBC Capital
\nCo-Manager: Oppenheimer
\nFiled: 10-11-19
\nListed Cash Raise: $70m<\/p>\n
\nSymbol: CNTG
\nDescription: They are a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): SVB Leerink, Evercore ISI
\nCo-Manager: Baird, BTIG
\nFiled: 10-11-19
\nListed Cash Raise: $69m<\/p>\n
\nSymbol: PGNY
\nDescription: They envision a world where anyone who wants to have a child can do so. Our mission is to make dreams of parenthood come true through healthy, timely and supported fertility journeys.
\nShares: 10 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $1.15b-$1.3b
\nTrade Date: Friday, 10\/25
\nUnderwriter(s): J.P. Morgan, Goldman Sachs & Co, BofA Merrill Lynch, Citigroup
\nCo-Manager: Piper Jaffray, SVB Leerink, TPG Capital
\nTerms Added: 10-15-19<\/p>\n
\nSymbol: PHAT
\nDescription: They are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.
\nShares: 7.9 million
\nPrice Range: $18.00-$20.00
\nMarket Cap: $465m-$520m
\nTrade Date: Friday, 10\/25
\nUnderwriter(s): Goldman Sachs, Jefferies, Evercore ISI
\nCo-Manager: Needham & Co.
\nTerms Added: 10-15-19<\/p>\n
\nSymbol: ONEW
\nDescription: They are one of the largest and fastest-growing premium recreational boat retailers in the United States with 60 stores comprising 20 dealer groups in 11 states.
\nShares: 3.157 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $171m-$190m
\nTrade Date: Thursday, 10\/24
\nUnderwriter(s): Goldman Sachs, Raymond James
\nCo-Manager(s): SunTrust Robinson Humphrey, B.Riley FBR
\nTerms Added: 10-15-19<\/p>\n
\nSymbol: DAO
\nDescription: For over a decade, Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages.
\nShares: 5.6 million ADSs
\nPrice Range: $15.00-$18.00
\nMarket Cap: $342m-$410m
\nTrade Date: Friday, 10\/25
\nUnderwriter(s): Citigroup, Morgan Stanley, Credit Suisse, CICC, HSBC
\nTerms Added: 10-15-19<\/p>\n
\nSymbol: AIH
\nDescription: They are a leading provider of aesthetic medical services in China.
\nShares: 2.5 million ADSs
\nPrice Range: $11.00-$13.00
\nMarket Cap: $260m-$307m
\nTrade Date: Friday, 10\/25
\nUnderwriter(s): Cantor, Haitong International
\nCo-Manager: Prime Number Capital, Maxim Group, CMBI, Zinvest Global
\nTerms Added: 10-15-19<\/p>\n
\nSymbol: CABA
\nDescription: They are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
\nShares: 5.8 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $315m-$360m
\nTrade Date: Friday, 10\/25
\nUnderwriter(s): Morgan Stanley, Cowen, Evercore ISI
\nTerms Added: 10-16-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-10400","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=10400"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10400\/revisions"}],"predecessor-version":[{"id":10401,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/10400\/revisions\/10401"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=10400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=10400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=10400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}